Galmed Pharmaceuticals
GLMD
GLMD
31 hedge funds and large institutions have $30.1M invested in Galmed Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
7
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $4.78K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $2K | -$3.33K | -5 | -63% |
|
|
BCM
28
Bourgeon Capital Management
Darien,
Connecticut
| $2K | +$2K | +3 | New |
|
|
FHA
29
Flagship Harbor Advisors
Boston,
Massachusetts
| $1K | – | – | – |
|
|
RFA
30
Reilly Financial Advisors
La Mesa,
California
| $1K | – | – | – |
|
|
VC
31
Vivo Capital
Palo Alto,
California
| – | -$7.14M | -5,396 | Closed |
|
|
MIH
32
Meitav Investment House
Bene-Beraq,
Israel
| – | -$4.69M | -3,551 | Closed |
|
|
PAM
33
Premier Asset Management
Chicago,
Illinois
| – | -$572K | -433 | Closed |
|
34
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$237K | -179 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$38K | -29 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | -$9K | -7 | Closed |
|